The Percentage of Prostate Needle Biopsy Cores with Carcinoma from the More Involved Side of the Biopsy as a Predictor of Prostate Specific Antigen Recurrence after Radical Prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database

Cancer

Volumn 98, Issue 11, 2003, Pages 2344-2350

  Freedland, Stephen J ^a,g   Aronson, William J ^a,b   Terris, Martha K ^c   Kane, Christopher J ^d   Amling, Christopher L ^e   Dorey, Frederick ^a   Presti Jr , Joseph C ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Vet Aff Gtr LA Hlth Care Syst ^*  (United States)

^c Section of Urology   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cores; Prostate carcinoma; Prostate needle biopsy; Prostate specific antigen recurrence; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

COMPARATIVE STUDY; DATA BASE; HUMAN; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; PREDICTION; PRIORITY JOURNAL; PROSTATE; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATECTOMY; REVIEW; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; BIOPSY, NEEDLE; CARCINOMA; DATABASES, FACTUAL; FUNCTIONAL LATERALITY; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0344412952     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11809     Document Type: Review

References (24)

1. D'Amico AV, Whittington R, Malkowicz SB, et al. Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J Clin Oncol. 2000;18:1164-1172.
2. Grossfeld GD, Latini DM, Lubeck DP, et al. Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE. Urology. 2002;59:560-565.
3. Presti JC Jr., Shinohara K, Bacchetti P, Tigrani V, Bhargava V. Positive fraction of systematic biopsies predicts risk of relapse after radical prostatectomy. Urology. 1998;52:1079-1084.
4. Freedland SJ, Csathy GS, Dorey F, Aronson WJ. Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. J Urol. 2002;167:516-520.
5. Freedland SJ, Aronson WJ, Terris MK, et al. Percent of prostate needle biopsy cores with cancer is a significant independent predictor of PSA recurrence following radical prostatectomy: results from the SEARCH database. J Urol. 2003;169:2136-2141.
6. Freedland SJ, Amling CL, Dorey F, et al. Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Urology. 2002;60:670-674.
7. Terris MK. Sensitivity and specificity of sextant biopsies in the detection of prostate cancer: preliminary report. Urology. 1999;54:486-489.
8. Borirakchanyavat S, Bhargava V, Shinohara K, Toke A, Carroll PR, Presti JC Jr. Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy. Urology. 1997;50:373-378.
9. Freedland SJ, Jalkut M, Dorey F, Sutter ME, Aronson WJ. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center. Urology. 2000;56:87-91.
10. Borboroglu PG, Comer SW, Riffenburgh RH, Amling CL. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol. 2000;163:158-162.
11. Harrell FE Jr., Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247:2543-2546.
12. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically ocalized prostate cancer. JAMA. 1998;280:969-974.
13. Freedland SJ, Aronson WJ, Presti JC Jr., et al. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database. J Urol. 2003;169:2129-2135.
14. Ou YC, Chen JT, Yang CR, et al. Preoperative prediction of extracapsular tumor extension at radical retropubic prostatectomy in Taiwanese patients with T1c prostate cancer. Jpn J Clin Oncol. 2002;32:172-176.
15. Graefen M, Haese A, Pichlmeier U, et al. A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. J Urol. 2001;165:857-863.
16. Elliott SP, Shinohara K, Logan SL, Carroll PR. Sextant prostate biopsies predict side and sextant site of extracapsular extension of prostate cancer. J Urol. 2002;168:105-109.
17. Presti JC Jr., Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol. 2000;163:163-166.
18. Gore JL, Shariat SF, Miles BJ, et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol. 2001;165:1554-1559.
19. Nelson CP, Rubin MA, Strawderman M, Montie JE, Sanda MG. Preoperative parameters for predicting early prostate cancer recurrence after radical prostatectomy. Urology. 2002;59:740-745.
20. D'Amico AV, Whittington R, Malkowicz SB, et al. Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer. Urology. 2000;55:572-577.
21. Gretzer MB, Epstein JI, Pound CR, Walsh PC, Partin AW. Substratification of Stage T1C prostate cancer based on the probability of biochemical recurrence. Urology. 2002;60:1034-1039.
22. Linson PW, Lee AK, Doytchinova T, et al. Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer? Urology. 2002;59:704-708.
23. Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. J Urol. 2000;163:174-178.
24. Moul JW, Kane CJ, Malkowicz SB. The role of imaging studies and molecular markers for selecting candidates for radical prostatectomy. Urol Clin North Am. 2001;28:459-472.